Abstract
Purpose
To characterize the clinical relevance of S. saccharolyticus and to identify criteria to distinguish between infection and contamination.
Methods
We retrospectively investigated clinical features of patients with S. saccharolyticus detection between June 2009 and July 2021. Based on six criteria, infection was considered likely for patients with a score from 3 to 6 points, infection was considered unlikely for patients with a score from 0 to 2 points. We performed group comparison and logistic regression to identify factors than are associated with likely infection. In addition, whole genome sequencing (WGS) of 22 isolates was performed.
Results
Of 93 patients in total, 44 were assigned to the group “infection likely” and 49 to the group “infection unlikely”. Multiple regression analysis revealed “maximum body temperature during hospital stay” to have the strongest predictive effect on likely infection (adjusted odds ratio 4.40, 95% confidence interval 2.07–9.23). WGS revealed two different clades. Compared to isolates from clade A, isolates from clade B were more frequently associated with implanted medical devices (3/10 vs. 9/12, p = 0.046) and a shorter time to positivity (TTP) (4.5 vs. 3, p = 0.016). Both clades did neither differ significantly in terms of causing a likely infection (clade A 7/10 vs. clade B 5/12, p = 0.23) nor in median length of hospital stay (28 vs. 15.5 days, p = 0.083) and length of stay at the ICU (21 vs. 3.5 days, p = 0.14).
Conclusion
These findings indicate that S. saccharolyticus can cause clinically relevant infections. Differentiation between infection and contamination remains challenging.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Staphylococcus (S.) saccharolyticus is a rare anaerobic member of the Gram-positive, coagulase-negative staphylococci (CoNS) group, and its pathogenic potential for humans and its clinical impact remain difficult to assess. One of the reasons why CoNS often are misjudged in clinical practice is the difficulty to distinguish between an infection and a contamination [1,2,3,4]. CoNS, including S. saccharolyticus, constitute a significant part of the human skin microbiome [5, 6]. In combination with its demanding microbiological culturing needs, it can be assumed that S. saccharolyticus is often under-detected in the routine microbiological workup of patient samples [7]. Up to date, there remains a dearth of data available on S. saccharolyticus.
Previously, S. saccharolyticus had been primarily associated with prosthetic joint infections and bloodstream infections [8, 9]. In addition, cases of spondylodiscitis [10,11,12], empyema [13], pneumonia [14] and others have been reported. However, most of these previously published data are limited either because they only pertain to single case reports or case series, and/or they do not include extensive microbiological and genomic characterization.
From a genomic standpoint, S. saccharolyticus can be divided into two subclades, A and B. These two subclades differ in subclade-specific genomic islands, e.g., subclade A shows a higher hyaluronidase and urease activity, which might indicate a greater pathogenic potential [8].
The aim of this study was to characterize the clinical relevance of S. saccharolyticus detected in human samples, by also taking into account the whole-genome sequencing based characterization, and to identify criteria to distinguish between infection and contamination.
Materials and methods
Study design
We conducted a retrospective cohort study at the Saarland University, Homburg, Germany on patients hospitalized between June 2009 and July 2021. The assent of the ethic committee was given (number 147/21). We searched the microbiology laboratory database for all isolates of S. saccharolyticus during the defined period. Clinical patient data were extracted from the hospital information system. The following variables were gathered for each patient: sample type in which S. saccharolyticus was detected, sex, age, medical history, current diagnosis, overall mortality, length of hospital stay in days, number of positive samples, implanted medical devices, time to positivity, polymicrobial growth, body temperature at admission, maximal body temperature during the hospital stay, body temperature of > 38 °C each two days before and after sampling, heart rate, blood pressure, respiratory rate, C-reactive protein (CRP), leucocyte count, procalcitonin, infection compatible with medical report, antibiotic therapy and antibacterial agent, clinical and laboratory response to therapy, and admission to and length of stay at the intensive care unit (ICU).
Classification into infection or contamination
We classified each patient case to have an infection or a contamination according to a score consisting of six criteria which were selected based on previous literature [2, 15,16,17,18]. One point was awarded for each criterion, with the score having a maximum of six points. The criteria were: S. saccharolyticus detected multiples times in different samples of the same patient; absence of other relevant detected pathogens; body temperature > 38 °C two days before and after sampling; CRP > 80 mg/L; a clinical suspicion of infection; and symptom improvement after antibiotic therapy. Patients with a score from 0 to 2 were rated as “infection unlikely/contamination”, patients with a score from 3 to 6 were classified as “infection likely”.
Whole-genome sequencing (WGS)
We performed WGS to further genetically characterize the isolates. To this end, 22 samples that were available were cultivated on Columbia Blood Agar and incubated under anaerobic conditions for 5 days at 37 °C. Afterwards, we confirmed identification of S. saccharolyticus by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Microflex LT and Biotyper 3.1, Bruker Daltonics).
For each isolate, the DNA extraction, library preparation, sequencing on a MiSeq Illumina platform (short-read sequencing, 2 × 300 bp) and post-sequencing procedure were performed as previously described [19]. Raw sequences were controlled for quality using fastp (v0·23·2 with parameters -q = 30 and -l = 45) and assembled with SPAdes 3.15.5 (with the option —careful and—only-assembler) [20, 21]. Draft genomes were curated by removing contigs with a length < 500 bp and/or coverage < 10×. The quality of the final draft was quality-controlled using Quast (v5.0.2) [22]. The complete draft genomes were processed through available databases using Abricate (https://github.com/tseemann/abricate) to identify antimicrobial resistance (NCBI, CARD, ARG-ANNOT, ResFinder, MEGARES databases) and plasmid type (PlasmidFinder database) to identify the Inc type of the plasmid [23, 24]. The genomes were annotated using Prokka v1.14.5 [25] and the core/accessory genome was estimated using Roary [26]. The species identification of each draft genome was done using mash (sub-command screen) by screening each draft genome to a database composed of a representative genome of each species present in the Microbial Genomes resource (https://www.ncbi.nlm.nih.gov/genome/microbes/). As two major clades were discussed in the literature, we compare our draft genomes to published genomes [8, 9]. Each draft genome was aligned to the representative genome reference from the Microbial Genomes resource (CP068029.1, strain 13T0028) using SKA [27]. The alignment was then analyzed with Gubbins 3.2.1 to define hqSNPs distance and phylogenetic relationship [28].
Antimicrobial susceptibility testing
We carried out antimicrobial susceptibility testing with 19 samples of the total of 22 sequenced strains. We used epsilometry (Liofilchem®, Roseto degli Abruzzi, Italy) for determining the Minimum Inhibitory Concentration (MIC) with the following antibiotics: penicillin, piperacillin/tazobactam, meropenem, vancomycin, clindamycin and metronidazole. The results were read out after 48 h of incubation at 35 °C under anaerobic conditions and evaluated according to the EUCAST clinical breakpoints up to Version 11.0.
Statistical analyses
We used SPSS® (Statistical Product and Service Solutions, IBM®, Release 28.0.1.0) for statistical analyses. Groups were compared with χ2 test or Fisher’s exact test for nominally scaled variables, and with Mann-Whitney U test (for non-normally distributed data) and t-test (for normally distributed data) for ordinal or ratio scaled variables. Additionally, a logistic regression was performed to assess potential risk factors associated with a likely infection.
Results
Classification into infection or contamination
In total, we identified 93 patients with detection of S. saccharolyticus (Fig. 1; Supplementary Table S1). We identified 44 patients with 3–6 points which were classified as group A “infection likely”, whereas 49 patients with 0–2 points were sorted to group B ”infection unlikely”. Table 1 provides an overview of the main characteristics of both groups. The two groups did not differ significantly in sex and median age. There were more men than women in both groups (39/44 [88.6%] in group A and 41/49 [83.7%] in group B, see Table 1). In contrast, other characteristics showed significant differences, for example, whether the type of sample material was a blood culture, median length of ICU stay and antibiotic therapy. Of note, the majority of isolates were detected in blood cultures (57/93), followed by wound swabs (23/93), tissue samples (6/93), skin swabs (3/93), aspirates (2/93) and urine samples (2/93).
Univariate regression identified four significant features, namely “length of hospital stay” (p = 0.004), “maximal body temperature during the hospital stay” (p < 0.001), “antibiotic therapy” (p = 0.017) and “stay at ICU” (p = 0.002) (Table 2). In multiple regression analysis, “maximal body temperature during hospital stay” had the strongest predictive effect with an adjusted odds ratio of 4.40 (95% confidence interval, CI, 2.07–9.23; p < 0.001) (Table 2).
Whole-genome sequencing (WGS)
WGS was performed on 12 and 10 samples from each group, respectively. Remaining patient samples were not recoverable and isolates were unavailable for sequencing. WGS revealed two clades, clade A and clade B as well as one outlier in between the two clades for which the SNPs distance is too high to be included in the clade B (Fig. 2). Comparison of both clades revealed significant clade-specific features (Table 3). Infection was likely among isolates from clade A in 7/10 cases, vs. 5/12 among clade B. Data on infections per clade are shown in the Appendix (Supplementary Table S2). Furthermore, in our study, there were more patients with medical devices in clade B compared to clade A (9/12 vs. 3/10, p = 0.046). However, these patients did not always necessarily have an infection (i.e. 4/9 in clade B with medical device had an infection, while 2/3 patients from clade A with a medical device had an infection). The median time to positivity (TTP) in clade A and B were 4.5 and 3, respectively, (p = 0.016). We found the median length of hospital stay and of stay at the ICU to be higher in clade A (28 days and 21 days) than in B (15.5 and 3.5 days, respectively), although not reaching statistical significance. Similarly, median heart rate was higher in clade A than in B (A: 90.5; B: 87), as were the median systolic and diastolic blood pressure (A: 124.5/70.5; B: 116/62.5) and the median CRP (A: 113.15; B: 96.7).
The core genomes, considered as genes clustering with a 95% identity and present in the whole population (i.e. prevalence of 100%), cover 1765 genes and 2,361,246 bp. For the 100% identity analysis, we used 100% identity and 100% coverage thresholds. 679 genes were only present in clade (A) The isolates from clade A all carried the delta-hemolysin gene hld. Only 48 genes were specific to clade B only, but 581 genes were absent in clade A but present in clade B and clade C. However, the core genome is quite small when a threshold of 100% identity is used. Only 62 predicted proteins are shared between clade A and (B) Overall, clade A present a higher protein-encoding content (average of 2651.4 ORFs) compared to clade B (average of 2606.1 ORFs) and a higher conserved core proteome (2115 ORFS predicted in the core-proteome vs. 1809 ORFS predicted in the core-proteome) indicating a higher stability and probably a lower genome decay (Fig. 3).
Antimicrobial susceptibility testing
Out of 22 sequenced strains, antimicrobial susceptibility testing results of 19 strains were available, while in three cases, the isolate was not culturable for susceptibility testing. The results showed phenotypic susceptibility to penicillin (19 out of 19 isolates), vancomycin (19/19), meropenem (13/13), piperacillin/tazobactam (12/12), and clindamycin (15/16) and showed resistance against metronidazole (12/12 isolates) and clindamycin (1/16 isolates). In only one strain of clade B the ermC and tet gene were present.
Discussion
In this retrospective cohort study on patients with S. saccharolyticus detection, we found that patients with a likely infection had more often pathogen detection in blood culture(s), a longer length of hospital stay, a higher maximal body temperature during the hospital stay, higher CRP levels, were more likely to be treated with antibiotics, were more likely to be treated at an ICU, and had a longer stay at an ICU. This could point to the pathogenic potential of S. saccharolyticus for humans to cause severe illness in systemic infections.
In most cases of S. saccharolyticus detection in blood cultures, TTP was longer than 4 days, which, along with the additional 24–48 h needed for antimicrobial susceptibility testing, might have led to suboptimal pathogen-targeted medical treatment. The slow growth of S. saccharolyticus remains an issue in diagnosis. The frequently used short TTP as an indicator for infection does not seem to be applicable for differentiation between infection or contamination of S. saccharolyticus.
Our regression analysis indicated an association between the maximal body temperature during the hospital stay and likely infection. However, the potential use of this variable as a predictor for infections caused by S. saccharolyticus remains questionable, since this parameter can only be assessed retrospectively after the hospital stay. Because the distinction between infection and contamination remains difficult based on clinical parameters alone, genetic markers may be helpful. For example, knowledge about the clade may be used as a predictive marker for disease severity.
Next-generation sequencing revealed two clades of S. saccharolyticus, A and B, in line with published data [8]. The distribution of our isolates in these two clades is relatively even. The findings of Brüggemann and colleagues indicates a possibly higher pathogenicity of clade A, which exhibited higher activities of two virulence factors, urease and hyaluronidase [8]. Our clinical data supports this observation: a higher proportion of isolates from clade A were found in patients with a probable infection in our cohort (isolates of clade A: 7/10 (70%) in group “infection likely” versus isolates of clade B: 5/12 (41.6%) in group “infection likely”). In addition, patients with clade A isolates stayed longer at the hospital, and showed higher median heart rate, blood pressure, and CRP levels.
Surprisingly, the presence of a medical device does not seem to have a relevant impact on the occurrence of an infection with S. saccharolyticus, unlike with other CoNS. A literature review of cases with S. saccharolyticus yielded that 17 of 56 previously published cases were foreign-body related infections [8,9,10, 29,30,31]. In our study, there were significantly more patients in clade B with implanted medical devices (9/12 (75%)) than in clade A (3/10 (30%)). However, the infection rate among patients with medical devices was not higher for clade B (4/9) compared to clade A (2/3). Due to the small event number and the lack of more detailed information, it is difficult to compare with previous literature, which had described clade B to be more prevalent in hip joint prosthetic infections [9].
TTP was shorter in clade B, which suggests, contrary to previous assumptions of higher pathogenicity of clade A, that the pathogenicity of this clade B might have been underestimated. The shorter TTP in clade B and a presumable faster growth as a result, could be a potential fitness advantage. Especially considering the lower protein-encoding content and lower conserved core proteome of clade B, the ongoing adaption to a new niche is probable and faster growth could be beneficial [8, 9]. The association between clades and virulence may provide a potential explanation for our findings regarding infection vs. contamination, which warrants further scrutiny.
Other scores to differentiate between infection and contamination were already proposed, for example by Hitzenbichler and colleagues [2] and Asai and colleagues [32]. Both studies aimed to evaluate the clinical relevance of CoNS other than Staphylococcus epidermidis. The scores are similar and consider infection likely if, for example, several blood cultures are positive or if there is an improvement in symptoms after therapy. Although S. saccharolyticus does not seem to play a particularly important role compared to other CoNS, our score is more differentiated, as it only compares positive S. saccharolyticus samples with each other. This allows a better evaluation than in a broader score or in comparison with more relevant CoNS, such as S. haemolyticus.
Our study has limitations. The proposed scoring system to distinguish between contamination and infection requires further external validation, i.e. ideally in another cohort within another setting and time, and also taking into account different weightings of individual criteria, which we did not investigate. Since we analyzed only detections of S. saccharolyticus, our score might overrate the importance of positive samples with S. saccharolyticus. Future validations could also extend to other members of the heterogeneous CoNS group. Another limitation is the inter-rater subjectivity of some variables such as “medical report indicates infection” and “symptom improvement after therapy”. Physicians have probably used similar parameters, such as CRP or temperature, to diagnose infection. This makes retrospective evaluation difficult. Prospective data collection by using standardized case report forms would help to address this limitation in future studies, albeit some imprecision with regard to clinical suspicion of infection might persist. Another limitation is missing data due to the retrospective character of the study, as well as the relatively low number of analyzed isolates of S. saccharolyticus, including those available for NGS and/or susceptibility testing, partly due to isolates not being culturable for susceptibility testing despite all efforts. Several parameters could not be ascertained, because the data were not documented or no longer available.
Furthermore, there is a certain degree of incorporation bias since the infection score that we generated on the basis of six criteria contained aspects that can be regarded as part of the clinically accepted reference standard, e.g., a CRP above a certain threshold. This is a common limitation in situations where a clear diagnostic gold standard is missing [33].
Here we describe the largest cohort of S. saccharolyticus samples to date. Of 93 patients, 44 (47.3%) were classified with likely infection. This corresponds to almost half of all detected samples and indicates a higher clinical relevance than initially assumed and previously reported [2]. Parameters like TTP, often used to differentiate between infection and contamination, seem to have less of a predictive meaning for S. saccharolyticus. This might contribute to misidentification as contamination.
In summary, our findings suggest that the role S. saccharolyticus as a clinically relevant pathogen may be underestimated. Further research is necessary to investigate the virulence of clade A and to identify additional predictive factors that can help to distinguish between contamination and infection. This will enable more accurate diagnosis and management of S. saccharolyticus infections to improve patient outcomes.
Data availability
All data supporting the findings of this study are available within the paper and its Supplementary Information. Genome sequences of the isolates investigated are available at the NCBI GenBank under project number PRJNA1070429.
References
Heilmann C, Ziebuhr W, Becker K. Are coagulase-negative staphylococci virulent? Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2019;25:1071–80.
Hitzenbichler F, Simon M, Salzberger B, Hanses F. Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital. Infection. 2017;45:179–86.
Papan C, Schröder M, Hoffmann M, Knoll H, Last K, Albrecht F, et al. Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit. Antimicrob Resist Infect Control. 2021;10:99.
Last K, Lepper PM, Jung P, Schäfers H-J, Boutin S, Heeg K, et al. Staphylococcus massiliensis isolated from human blood cultures, Germany, 2017–2020. Eur J Clin Microbiol Infect Dis. 2022;41:663–9.
Ahle CM, Stødkilde K, Afshar M, Poehlein A, Ogilvie LA, Söderquist B, et al. Staphylococcus saccharolyticus: an overlooked human skin colonizer. Microorganisms. 2020;8:E1105.
Michels R, Last K, Becker SL, Papan C. Update on coagulase-negative staphylococci-what the Clinician should know. Microorganisms. 2021;9:830.
Ahle CM, Stødkilde-Jørgensen K, Poehlein A, Streit WR, Hüpeden J, Brüggemann H. Comparison of three amplicon sequencing approaches to determine staphylococcal populations on human skin. BMC Microbiol. 2021;21:221.
Brüggemann H, Poehlein A, Brzuszkiewicz E, Scavenius C, Enghild JJ, Al-Zeer MA, et al. Staphylococcus saccharolyticus isolated from blood cultures and prosthetic joint infections exhibits excessive genome decay. Front Microbiol. 2019;10:478.
Söderquist B, Afshar M, Poehlein A, Brüggemann H. Staphylococcus saccharolyticus Associated with Prosthetic Joint infections: clinical features and genomic characteristics. Pathog Basel Switz. 2021;10:397.
Trojani M-C, Lamy B, Ruimy R, Amoretti N, Risso K, Roux C. An unusual Staphylococcus saccharolyticus spondylodiscitis post kyphoplasty: a case report. BMC Infect Dis. 2020;20:539.
Mikhael MM, Bach HG, Huddleston PM, Maus TP, Berbari EF. Multilevel diskitis and vertebral osteomyelitis after diskography. Orthopedics. 2009;32:60.
Godreuil S, Jean-Pierre H, Morel J, Darbas H, Jumas-Bilak E, Bañuls A-L, et al. Unusual case of spondylodiscitis due to Staphylococcus saccharolyticus. Joint Bone Spine. 2005;72:91–3.
Wang P, Liu Y, Xu Y, Xu Z. Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review. Med (Baltim). 2020;99:e20686.
Wu X, Yu C, Wang X. A case of Staphylococcus saccharolyticus pneumonia. Int J Infect Dis IJID off Publ Int Soc Infect Dis. 2009;13:e43–46.
Osaki S, Kikuchi K, Moritoki Y, Motegi C, Ohyatsu S, Nariyama T, et al. Distinguishing coagulase-negative Staphylococcus bacteremia from contamination using blood-culture positive bottle detection pattern and time to positivity. J Infect Chemother off J Jpn Soc Chemother. 2020;26:672–5.
Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase-negative Staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol. 2005;26:559–66.
Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D. Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol. 2005;26:697–702.
Elzi L, Babouee B, Vögeli N, Laffer R, Dangel M, Frei R, et al. How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18:E355–361.
Nurjadi D, Kocer K, Chanthalangsy Q, Klein S, Heeg K, Boutin S. New Delhi Metallo-Beta-Lactamase facilitates the emergence of Cefiderocol Resistance in Enterobacter cloacae. Antimicrob Agents Chemother. 2022;66:e0201121.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol J Comput Mol Cell Biol. 2012;19:455–77.
Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinforma Oxf Engl. 2018;34:i884–90.
Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinforma Oxf Engl. 2013;29:1072–5.
Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I, et al. Validating the AMRFinder Tool and Resistance Gene Database by using Antimicrobial Resistance genotype-phenotype correlations in a Collection of isolates. Antimicrob Agents Chemother. 2019;63:e00483–19.
Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895–903.
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinforma Oxf Engl. 2014;30:2068–9.
Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinforma Oxf Engl. 2015;31:3691–3.
Harris SRSKA. Split Kmer Analysis Toolkit for Bacterial Genomic Epidemiology. bioRxiv. 2018;:453142.
Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43:e15.
Krishnan S, Haglund L, Ashfaq A, Leist P, Roat T. Prosthetic valve endocarditis due to Staphylococcus saccharolyticus. Clin Infect Dis off Publ Infect Dis Soc Am. 1996;22:722–3.
Schneeberger AG, Gilbart MK, Sheikh R, Gerber C, Ruef C. Non-purulent low-grade infection as cause of pain following shoulder surgery: preliminary results. Chir Organi Mov. 2009;93(Suppl 1):S71–77.
Schneeberger AG, Yian E, Steens W. Injection-induced low-grade infection of the shoulder joint: preliminary results. Arch Orthop Trauma Surg. 2012;132:1387–92.
Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Watanabe H, et al. Clinical characteristics and relevance of coagulase-negative Staphylococci other than S. epidermidis by positive blood culture. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2021;54:632–8.
van Houten CB, Naaktgeboren CA, Ashkenazi-Hoffnung L, Ashkenazi S, Avis W, Chistyakov I, et al. Expert panel diagnosis demonstrated high reproducibility as reference standard in infectious diseases. J Clin Epidemiol. 2019;112:20–7.
Acknowledgements
The authors would like to thank Nicole Henny, Martina Birke, and Sandra Rauch for their excellent technical support. Additionally, the authors are grateful for input provided by Jan Philipp Jung and Judith Fürstenberg.
Funding
No external funding was available for this study.
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
RM, CP and KL conceived the study and its design, had full access to the data, and take responsibility for the integrity of the data and accuracy of the analysis. RM and SB organized and entered data. RM, CP and KL performed data analyses. All authors contributed to data interpretation. RM, CP and KL wrote the main draft of the manuscript. All authors contributed to the final drafting of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
This study was approved by the ethical committee of the Ärztekammer des Saarlandes (reference number 147/21).
Conflict of interest
The authors have no competing interests to declare.
Competing interests
The authors declare no competing interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Michels, R., Papan, C., Boutin, S. et al. Clinical relevance of Staphylococcus saccharolyticus detection in human samples: a retrospective cohort study. Infection (2024). https://doi.org/10.1007/s15010-024-02334-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-024-02334-6